NASOPHARYNGEAL CANCERS

Clinical trials for NASOPHARYNGEAL CANCERS explained in plain language.

Never miss a new study

Get alerted when new NASOPHARYNGEAL CANCERS trials appear

Sign up with your email to follow new studies for NASOPHARYNGEAL CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug AVZO-1418 enters human trials for Hard-to-Treat cancers

Disease control Recruiting now

This study tests a new drug called AVZO-1418 in people with advanced solid tumors that have spread. The main goals are to find a safe dose and see if the drug can shrink tumors. About 480 adults will take part in this first human trial.

Matched conditions: NASOPHARYNGEAL CANCERS

Phase: PHASE1, PHASE2 • Sponsor: Avenzo Therapeutics, Inc. • Aim: Disease control

Last updated May 26, 2026 12:02 UTC

NASOPHARYNGEAL CANCERS

Get alerted when new NASOPHARYNGEAL CANCERS trials appear

New drug AVZO-1418 enters human trials for Hard-to-Treat cancers